The QUANTEC criteria for parotid gland dose and their efficacy to prevent moderate to severe patient-rated xerostomia

References

• Nutting CM, Morden JP, Harrington KJ, Urbano TG, Bhide SA, Clark C, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011;12:127–136.
   PubMed Web of Science ®Google Scholar
• Kam MK, Leung SF, Zee B, Chau RM, Suen JJ, Mo F, et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 2007;25:4873–4879.
   PubMed Web of Science ®Google Scholar
• Jellema AP, Slotman BJ, Doornaert P, Leemans CR, Langendijk JA. Impact of radiation-induced xerostomia on quality of life after primary radiotherapy among patients with head and neck cancer. Int J Radiat Oncol Biol Phys 2007; 69:751–760.
   PubMed Web of Science ®Google Scholar
• Bentzen SM, Constine LS, Deasy JO, Eisbruch A, Jackson A, Marks LB, et al. Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): an introduction to the scientific issues. Int J Radiat Oncol Biol Phys 2010; 76:S3–9.
   PubMed Web of Science ®Google Scholar
• Deasy JO, Moiseenko V, Marks L, Chao KS, Nam J, Eisbruch A. Radiotherapy dose-volume effects on salivary gland function. Int J Radiat Oncol Biol Phys 2010;76:S58–S63.
   PubMed Web of Science ®Google Scholar
• Moiseenko V, Wu J, Hovan A, Saleh Z, Apte A, Deasy JO, et al. Treatment Planning Constraints to Avoid Xerostomia in Head-and-Neck Radiotherapy: An Independent Test of QUANTEC Criteria Using a Prospectively Collected Dataset. Int J Radiat Oncol Biol Phys 2012;82:1108–14.
   PubMed Web of Science ®Google Scholar
• Beetz I, Schilstra C, Burlage FR, Koken PW, Doornaert P, Bijl HP, et al. Development of NTCP models for head and neck cancer patients treated with three-dimensional conformal radiotherapy for xerostomia and sticky saliva: The role of dosimetric and clinical factors. Radiother Oncol 2012; 105:86–93.
   PubMed Web of Science ®Google Scholar
• Pow EH, Kwong DL, McMillan AS, Wong MC, Sham JS, Leung LH, et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 2006;66:981–991.
   PubMed Web of Science ®Google Scholar
• van de Water TA, Bijl HP, Westerlaan HE, Langendijk JA. Delineation guidelines for organs at risk involved in radiation-induced salivary dysfunction and xerostomia. Radiother Oncol 2009;93:545–552.
   PubMed Web of Science ®Google Scholar
• Bjordal K, de Graeff A, Fayers PM, Hammerlid E, van Pottelsberghe C, Curran D, et al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H & N35) in head and neck patients. EORTC Quality of Life Group. Eur J Cancer 2000;36:1796–1807.
   PubMed Web of Science ®Google Scholar
• Lee TF, Fang FM. Quantitative analysis of normal tissue effects in the clinic (QUANTEC) guideline validation using quality of life questionnaire datasets for parotid gland constraints to avoid causing xerostomia during head-and-neck radiotherapy. Radiother Oncol 2013 Mar; 106:352–8.
   PubMed Web of Science ®Google Scholar
• Leal SC, Bittar J, Portugal A, Falcao DP, Faber J, Zanotta P. Medication in elderly people: its influence on salivary pattern, signs and symptoms of dry mouth. Gerodontology 2010 Jun; 27:129–33.
   PubMed Web of Science ®Google Scholar
• Ghezzi EM, Ship JA. Aging and secretory reserve capacity of major salivary glands. J Dent Res 2003; 82:844–848.
   PubMed Web of Science ®Google Scholar
• Pringle S, Van der Zwaag M, Vos L, Stokman M, Van Os R, Coppes R, et al. Characterisation Of Human Salivary Gland Stem Cells To Rescue Radiation-induced Salivary Gland Damage 2011;International Society for Stem Cell Research, ISSCR annual meeting, Toronto 2011(International Society for Stem Cell Research, ISSCR annual meeting, Toronto 2011).
   Google Scholar
• van de Water TA, Lomax AJ, Bijl HP, de Jong ME, Schilstra C, Hug EB, et al. Potential Benefits of Scanned Intensity-Modulated Proton Therapy Versus Advanced Photon Therapy with Regard to Sparing of the Salivary Glands in Oropharyngeal Cancer. Int J Radiat Oncol Biol Phys 2011; 79:1216–24.
   PubMed Web of Science ®Google Scholar
• van der Laan HP, van de Water TA, van Herpt HE, Christianen ME, Bijl HP, Korevaar EW, et al. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study. Acta Oncol 2013;52: 561–9.
   PubMed Web of Science ®Google Scholar